BioMarin’s R&D update next Tuesday will be the biggest thing in biotech in the coming week, says Adam Feuerstein, Sr. Columnist at TheStreet.
Subscribe to TheStreetTV on YouTube:
For more content from TheStreet visit:
Check out all our videos:
Follow TheStreet on Twitter:
Like TheStreet on Facebook:
Follow TheStreet on LinkedIn:
Follow TheStreet on Google+:
source






















